• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素 D 受体(VDR)TaqI 多态性、维生素 D 与炎症性肠病患者的骨密度。

Vitamin D receptor (VDR) TaqI polymorphism, vitamin D and bone mineral density in patients with inflammatory bowel diseases.

机构信息

Department of Gastroenterology, Human Nutrition and Internal Medicine, Poznan University of Medical Sciences, Poland.

Institute of Human Genetics, Polish Academy of Sciences, Poznań, Poland.

出版信息

Adv Clin Exp Med. 2019 Jul;28(7):955-960. doi: 10.17219/acem/97376.

DOI:10.17219/acem/97376
PMID:30929318
Abstract

BACKGROUND

A common feature in the etiology of inflammatory bowel disease (IBD) and osteoporosis is a complex genetic background. Moreover, it has been shown that some of the susceptibility loci overlap for both diseases. One of the genes that may be involved in the pathogenesis of IBD as well as decreased bone mass is the vitamin D receptor (VDR) gene.

OBJECTIVES

The aim of this study was to investigate the association of the TaqI polymorphism (rs731236, c.1056T >C) in the VDR gene with serum vitamin D concentration and bone mineral density (BMD) in patients with IBD.

MATERIAL AND METHODS

A total of 172 IBD patients (85 with Crohn's disease (CD) and 87 with ulcerative colitis (UC)) and 39 healthy controls were enrolled in the study. Polymorphism was determined with polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP). Bone mineral density was measured at the lumbar spine (L2-L4) and the femoral neck (FN) using dual-energy x-ray absorptiometry (DEXA). Serum concentrations of 25-hydroxyvitamin D were determined using electrochemiluminescence binding assay (ECLIA).

RESULTS

Our studies revealed that serum vitamin D concentration in IBD patients was not lowered in comparison with healthy controls. Patients with CD presented more advanced osteopenia and osteoporosis. Individuals with UC carrying the TaqI tt genotype of VDR gene showed significantly higher FN BMD than carriers of TT and Tt genotypes (p = 0.02). Moreover, tt genotype was present with higher frequency in UC patients than in controls and CD patients (23% vs 7.7% and 16.5%, respectively).

CONCLUSIONS

The tt genotype may have a protective effect on BMD in UC patients.

摘要

背景

炎症性肠病(IBD)和骨质疏松症的病因有一个共同的特点,就是存在复杂的遗传背景。此外,已经表明这两种疾病的一些易感基因座存在重叠。维生素 D 受体(VDR)基因可能参与 IBD 以及骨量减少的发病机制。

目的

本研究旨在探讨 VDR 基因 TaqI 多态性(rs731236,c.1056T>C)与 IBD 患者血清维生素 D 浓度和骨密度(BMD)的关系。

材料和方法

共纳入 172 例 IBD 患者(85 例克罗恩病(CD)和 87 例溃疡性结肠炎(UC))和 39 名健康对照者。采用聚合酶链反应(PCR)和限制性片段长度多态性(RFLP)方法检测多态性。采用双能 X 线吸收法(DEXA)测定腰椎(L2-L4)和股骨颈(FN)的骨密度。采用电化学发光结合测定法(ECLIA)测定血清 25-羟维生素 D 浓度。

结果

我们的研究表明,与健康对照组相比,IBD 患者的血清维生素 D 浓度并未降低。CD 患者表现出更严重的骨质疏松症和骨质疏松症。携带 VDR 基因 TaqI tt 基因型的 UC 患者的 FN BMD 明显高于 TT 和 Tt 基因型携带者(p=0.02)。此外,UC 患者的 tt 基因型比对照组和 CD 患者更常见(23%比 7.7%和 16.5%)。

结论

tt 基因型可能对 UC 患者的 BMD 有保护作用。

相似文献

1
Vitamin D receptor (VDR) TaqI polymorphism, vitamin D and bone mineral density in patients with inflammatory bowel diseases.维生素 D 受体(VDR)TaqI 多态性、维生素 D 与炎症性肠病患者的骨密度。
Adv Clin Exp Med. 2019 Jul;28(7):955-960. doi: 10.17219/acem/97376.
2
Vitamin D, Vitamin D Receptor (VDR) Gene Polymorphisms (ApaI and FokI), and Bone Mineral Density in Patients With Inflammatory Bowel Disease.维生素 D、维生素 D 受体(VDR)基因多态性(ApaI 和 FokI)与炎症性肠病患者的骨密度。
J Clin Densitom. 2021 Apr-Jun;24(2):233-242. doi: 10.1016/j.jocd.2020.10.009. Epub 2020 Oct 24.
3
The frequency of low bone mineral density and its associated risk factors in patients with inflammatory bowel diseases.炎症性肠病患者低骨密度的频率及其相关危险因素。
Int J Rheum Dis. 2010 Aug;13(3):259-65. doi: 10.1111/j.1756-185X.2010.01542.x.
4
Association of vitamin D receptor gene polymorphism (TaqI and Apa1) with bone mineral density in North Indian postmenopausal women.维生素 D 受体基因多态性(TaqI 和 Apa1)与印度北部绝经后妇女骨密度的关系。
Gene. 2018 Jun 15;659:123-127. doi: 10.1016/j.gene.2018.03.052. Epub 2018 Mar 17.
5
Vitamin D receptor (VDR) gene polymorphism and osteoporosis risk in White British men.英国白人男性维生素D受体(VDR)基因多态性与骨质疏松症风险
Ann Hum Biol. 2019 Aug;46(5):430-433. doi: 10.1080/03014460.2019.1659851. Epub 2019 Sep 11.
6
The Role of Vitamin D and Vitamin D Receptor Gene Polymorphisms in the Course of Inflammatory Bowel Disease in Children.维生素 D 及其受体基因多态性在儿童炎症性肠病病程中的作用。
Nutrients. 2024 Jul 13;16(14):2261. doi: 10.3390/nu16142261.
7
The c.29T>C polymorphism of the transforming growth factor beta-1 (TGFB1) gene, bone mineral density and the occurrence of low-energy fractures in patients with inflammatory bowel disease.转化生长因子β-1(TGFB1)基因的c.29T>C多态性、骨密度与炎症性肠病患者低能量骨折的发生情况
Mol Biol Rep. 2017 Dec;44(6):455-461. doi: 10.1007/s11033-017-4131-2. Epub 2017 Oct 9.
8
Genetic variants of MTHFR gene in relation to folic acid levels and bone mineral density in Polish patients with inflammatory bowel disease.MTHFR 基因遗传变异与波兰炎症性肠病患者叶酸水平和骨密度的关系。
J Appl Genet. 2024 Feb;65(1):73-81. doi: 10.1007/s13353-023-00792-6. Epub 2023 Oct 11.
9
Bone mineral density, body height, and vitamin D receptor gene polymorphism in middle-aged men.中年男性的骨矿物质密度、身高与维生素D受体基因多态性
Ann Med. 2005;37(5):383-92. doi: 10.1080/07853890510011958.
10
Bone density and bone metabolism in patients with inflammatory bowel disease.炎症性肠病患者的骨密度和骨代谢。
Saudi J Gastroenterol. 2012 Jul-Aug;18(4):241-7. doi: 10.4103/1319-3767.98428.

引用本文的文献

1
Gut, bone, and muscle: the triad of osteosarcopenia in inflammatory bowel disease.肠道、骨骼与肌肉:炎症性肠病中的骨肌减少三联征
Intest Res. 2025 Jul;23(3):254-289. doi: 10.5217/ir.2024.00185. Epub 2025 Apr 29.
2
Mechanisms Underlying Bone Loss Associated with Gut Inflammation.与肠道炎症相关的骨丢失的机制。
Int J Mol Sci. 2019 Dec 15;20(24):6323. doi: 10.3390/ijms20246323.
3
The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management.维生素 D 在炎症性肠病中的作用:从发病机制到治疗策略。
Nutrients. 2019 May 7;11(5):1019. doi: 10.3390/nu11051019.